Leukapheresis in Childhood Acute Leukemias: Single-Center Experience

REFERENCES

• Porcu P, Farag S, Marcucci G, Cataland SR, Leukocytoreduction for acute leukemia. Ther Apher. 2002;6:15–23.
   PubMedGoogle Scholar
• Majhail NS, Lichtin AE. Acute leukemia with a very high leukocyte count: confronting a medical emergency. Cleve Clin J of Med. 2004;71:633–637.
   PubMed Web of Science ®Google Scholar
• Ganzel C, Becker J, Mintz PD, Hyperleukocytosis, leukostasis and leukapheresis: practice management. Blood Rev. 2012;26:117–122.
   PubMed Web of Science ®Google Scholar
• Inaba H, Fan Y, Pounds S, Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis. Cancer. 2008;113:522–529.
   PubMed Web of Science ®Google Scholar
• Koenig MK, Sitton CW, Wang M, Slopis JM. Central nervous system complications of blastic hyperleukocytosis in childhood acute lymphoblastic leukemia: diagnostic and prognostic implications. J Child Neurol. 2008;23:1347–1352.
   Google Scholar
• Lowe EJ, Pui CH, Hancock ML, Early complications in children with acute lymphoblastic leukemia presenting with hyperleukocytosis. Pediatr Blood Cancer. 2005;45:10–15.
   PubMed Web of Science ®Google Scholar
• Kulkarni KP, Marwaha RK. Childhood acute lymphoblastic leukemia with hyperleukocytosis at presentation: perspective and lessons from a tertiary care institution in India. Asia- Pacific J Clin Oncol. 2011;7:185–187.
   Google Scholar
• Goenka P, Chait M, Hitti IF, Acute leukostasis pulmonary distress syndrome. J Fam Pract. 1992;35:445–446, 449.
   Google Scholar
• Chang MC, Chen TY, Tang JL, Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage. Am J Hematol. 2007;82:976–980.
   PubMed Web of Science ®Google Scholar
• Novotny JR, Müller-Beissenhirtz H, Herget-Rosenthal S, Grading of symptoms in hyperleukocytic leukaemia: a clinical model for the role of different blast types and promyelocytes in the development of leukostasis syndrome. Eur J Haematol. 2005; 74:501–510.
   PubMed Web of Science ®Google Scholar
• Bug G, Anargyrou K, Tonn T, Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyerleukocytosis. Transfusion. 2007;47:1843–1850.
   PubMed Web of Science ®Google Scholar
• Basade M, Dhar AK, Kulkarni SS, Rapid cytoreduction in childhood leukemic hyperleukocytosis by conservative therapy. Med Pediatr Oncol. 1995;25:204–207.
   PubMedGoogle Scholar
• Bunin NJ, Kunkel K, Callihan TR. Cytoreductive procedures in the early management in cases of leukemia and hyperleukocytosis in children. Med Pediatr Oncol. 1987;15:232–235.
   PubMedGoogle Scholar
• Haase R, Merkel N, Diwan O, Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience. Klin Padiatr. 2009;221:374–378.
   PubMed Web of Science ®Google Scholar
• Tan D, Hwang W, Goh YYT. Therapeutic leukapheresis in hyperleukocytic leukaemias–the experience of a tertiary institution in Singapore. Ann Acad Med Singapore. 2005;34:229–234.
   PubMed Web of Science ®Google Scholar
• De Santis GC, de Oliveira LC, Romano LG, Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia. J Clin Apher. 2011;26:181–185.
   Google Scholar
• Piro E, Carillio G, Levato L, Reversal of leukostasis-related pulmonary distress syndrome after leukapheresis and low-dose chemotherapy in acute myeloid leukemia. J Clin Oncol. 2011;29:e725–e726.
   PubMed Web of Science ®Google Scholar
• Giles FJ, Shen Y, Kantarjian HM, Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leuk Lymphoma. 2001;42:67–73.
   PubMed Web of Science ®Google Scholar
• Szczepiorkowski ZM, Winters JL, Bandarenko N, Guidelines on the use of therapeutic apheresis in clinical practice—evidence-based approach from the apheresis applications committee of the american society for apheresis. J Clin Apheresis. 2010;25:83–177
   PubMed Web of Science ®Google Scholar
• Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute lymhoblastic or nonlymphoblastic leukemia. J Clin Oncol. 1985;3:1590–1595.
   PubMed Web of Science ®Google Scholar
• Ventura GJ, Hester JP, Smith TL, Acute myeloblastic leukemia with hyperleukocytosis: Risk factors for early mortality in induction. Am J Hematol. 1988;27:34–37.
   PubMed Web of Science ®Google Scholar
• Maurer HS, Steinherz PG, Gaynon PS, The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia. J Clin Oncol. 1988;6:1425–1432.
   PubMed Web of Science ®Google Scholar
• Witt V, Stegmayr B, Ptak J, World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry. Transfusion and Apheresis Sci. 2008;39:255–260.
   Google Scholar
• Stefanutti C, Lanti A, Di Giacomo S, Therapeutic apheresis in low weight patients. Technical feasibility, tolerance, compliance, and risks. Transfusion and Apheresis Sci. 2004;31:3–10.
   Google Scholar
• Karapinar B, Cura A. Complications of central venous catheterization in critically ill children. Pediatr Int. 2007;49:593–599.
   Google Scholar
• Sheridan RL, Weber JM. Mechanical and infectious complications of central venous cannulation in children: lessons learned from a 10-year experience placing more than 1000 catheters. J Burn Care Res. 2006;27:713–718.
   PubMed Web of Science ®Google Scholar
• Ruggiero A, Attinà G, Piastra M, Severe hyperleukocytosis and multifocal intracranial haemorrhage: not always a fatal outcome. Int J Hematol. 2009;90:87–90.
   Google Scholar